DelveInsight Business Research LL

DelveInsight’s ‘Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the pancreatic cancer historical and forecasted epidemiology as well as the pancreatic cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Key Highlights of the Pancreatic Cancer Market 

• The Key Companies working in the Pancreatic Cancer market include AstraZeneca

• Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, Bristol Myers Squibb and many others 

• The Key Therapies working in the Pancreatic Cancer market include Octagam, Brepocitinib, Ultomiris, Efgartigimod, PF-06823859, and many others.

Pancreatic Cancer Overview

Pancreatic cancer begins in the tissues of the pancreas – an organ in the abdomen that lies behind the lower part of the stomach. The pancreas releases enzymes that aid digestion and produces hormones that help manage blood sugar. Pancreatic cancer is a disease in which malignant (cancer) cells form in the tissues of the pancreas. Several types of growth can occur in the pancreas, including cancerous and noncancerous tumors. The most common type of cancer that forms in the pancreas begins in the cells that line the ducts that carry digestive enzymes out of the pancreas (pancreatic ductal adenocarcinoma). Pancreatic cancer is seldom detected at its early stages when it is most curable, and this is because it often does not cause symptoms until after it has spread to other organs. Pancreatic cancer treatment options are chosen based on the extent of the cancer. Options may include surgery, chemotherapy, radiation therapy, or a combination of these.

Pancreatic Cancer Epidemiology Insights

• In 2021, the total incident cases of pancreatic cancer in the 7MM countries were 175,767 cases, and these cases are anticipated to increase during the study period.

• Among the European countries, Germany had the highest incident cases of pancreatic cancer in 2021, i.e., 21,859 cases, followed by France which had 14,989 incident cases in 2021. On the other hand, Spain had the lowest incident cases of pancreatic cancer, i.e. 8,566 cases in 2021. Japan had 43,170 incident cases of pancreatic cancer in 2021.

• In terms of stage-specific incident cases, a maximum number of patients were observed for distant pancreatic cancer. This was followed by regional and localized pancreatic cancer.

Click here to learn more about the Pancreatic Cancer Market Landscape

The Report Covers the Pancreatic Cancer  Epidemiology Segmented by:

• Pancreatic Cancer-diagnosed cases 

• Pancreatic Cancer incident cases

• Pancreatic Cancer prevalent cases 

• Pancreatic Cancer treatment cases 

Pancreatic Cancer Market Outlook 

Pancreatic cancer is enlisted as one of the most common cancers and the seventh-highest cause of cancer mortality worldwide. The incidence of pancreatic cancer is increasing in the Western world. The incidence of pancreatic adenocarcinoma is rising in the developed world, and modifiable lifestyle factors such as alcohol and obesity may play an essential role. The five-year survival from this disease is as low as 2% in some countries, despite improvements in surgical technique, chemotherapy regimens, and the introduction of neoadjuvant chemoradiotherapy. Currently, the main therapeutic approach for pancreatic cancer patients is majorly based on chemotherapy.

Pancreatic ductal adenocarcinoma patients constitute the major portion of the pancreatic cancer-affected population. Although advancements have been made in operative techniques and chemotherapy with time, survival rates for pancreatic cancer patients remain low. Diagnosis of pancreatic cancer in the late or advanced stage i.e. Stage III, and Stage IV is the main reason for low survival. Many patients are not eligible for the treatment by this time, and in most patients, the tumor has become metastatic. 

Key Companies Working in the Pancreatic Cancer Market

• AstraZeneca

• Merck 

• Bayer

• Roche

• Celgene

• Bristol Myers Squibb

And many others 

Pancreatic Cancer Therapies Covered and Analyzed in the Report

• Octagam

• Brepocitinib

• Ultomiris

• Efgartigimod

• PF-06823859

And many others.

Learn more about the Key Companies and Emerging Therapies in the Pancreatic Cancer  Market

Table of Contents 

1. Key Insights 

2. Pancreatic Cancer Introduction 

3. Executive Summary of Pancreatic Cancer            

4. Disease Background and Overview

5. Epidemiology and Patient Population

6. Pancreatic Cancer Emerging Therapies

7. Pancreatic Cancer Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Pancreatic Cancer Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services